Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure

BackgroundHepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) has significant morbidity and mortality and is associated with the induction of cytokines/chemokines, which might contribute to the pathogenesis of liver injury. This study aimed to explore the cytokine/chemokine profiles...

Full description

Bibliographic Details
Main Authors: Bingbing Zhu, Fangyuan Gao, Yuxin Li, Ke Shi, Yixin Hou, Jialiang Chen, Qun Zhang, Xianbo Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1133656/full
_version_ 1827958993390141440
author Bingbing Zhu
Fangyuan Gao
Yuxin Li
Ke Shi
Yixin Hou
Jialiang Chen
Qun Zhang
Xianbo Wang
author_facet Bingbing Zhu
Fangyuan Gao
Yuxin Li
Ke Shi
Yixin Hou
Jialiang Chen
Qun Zhang
Xianbo Wang
author_sort Bingbing Zhu
collection DOAJ
description BackgroundHepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) has significant morbidity and mortality and is associated with the induction of cytokines/chemokines, which might contribute to the pathogenesis of liver injury. This study aimed to explore the cytokine/chemokine profiles of patients with HBV-ACLF and develop a composite clinical prognostic model.MethodsWe prospectively collected blood samples and the clinical data of 107 patients with HBV-ACLF admitted to the Beijing Ditan Hospital. The concentrations of 40-plex cytokines/chemokines were measured in 86 survivors and 21 non-survivors using the Luminex assay. Discrimination between the cytokine/chemokine profiles in different prognosis groups was analyzed using the multivariate statistical techniques of principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA). An immune-clinical prognostic model was obtained using multivariate logistic regression analysis.ResultsThe PCA and PLS-DA indicated that cytokine/chemokine profiling could clearly distinguish patients with different prognoses. A total of 14 cytokines, namely, IL-1β, IL-6, IL-8, IL-10, TNF-α, IFN-γ, CXCL1, CXCL2, CXCL9, CXCL13, CX3CL1, GM-SCF, CCL21, and CCL23, were significantly correlated with disease prognosis. Multivariate analysis identified CXCL2, IL-8, total bilirubin, and age as independent risk factors that constituted the immune-clinical prognostic model, which showed the strongest predictive value of 0.938 compared with those of the Chronic Liver Failure Consortium (CLIF-C) ACLF (0.785), Model for End-Stage Liver Disease (MELD) (0.669), and MELD-Na (0.723) scores (p < 0.05 for all).ConclusionThe serum cytokine/chemokine profiles correlated with the 90-day prognosis of patients with HBV-ACLF. The proposed composite immune-clinical prognostic model resulted in more accurate prognostic estimates than those of the CLIF-C ACLF, MELD, and MELD-Na scores.
first_indexed 2024-04-09T15:44:41Z
format Article
id doaj.art-e0a85fd5399e435e91cee26ccabae7cc
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-09T15:44:41Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-e0a85fd5399e435e91cee26ccabae7cc2023-04-27T05:17:38ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-04-011410.3389/fimmu.2023.11336561133656Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failureBingbing ZhuFangyuan GaoYuxin LiKe ShiYixin HouJialiang ChenQun ZhangXianbo WangBackgroundHepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) has significant morbidity and mortality and is associated with the induction of cytokines/chemokines, which might contribute to the pathogenesis of liver injury. This study aimed to explore the cytokine/chemokine profiles of patients with HBV-ACLF and develop a composite clinical prognostic model.MethodsWe prospectively collected blood samples and the clinical data of 107 patients with HBV-ACLF admitted to the Beijing Ditan Hospital. The concentrations of 40-plex cytokines/chemokines were measured in 86 survivors and 21 non-survivors using the Luminex assay. Discrimination between the cytokine/chemokine profiles in different prognosis groups was analyzed using the multivariate statistical techniques of principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA). An immune-clinical prognostic model was obtained using multivariate logistic regression analysis.ResultsThe PCA and PLS-DA indicated that cytokine/chemokine profiling could clearly distinguish patients with different prognoses. A total of 14 cytokines, namely, IL-1β, IL-6, IL-8, IL-10, TNF-α, IFN-γ, CXCL1, CXCL2, CXCL9, CXCL13, CX3CL1, GM-SCF, CCL21, and CCL23, were significantly correlated with disease prognosis. Multivariate analysis identified CXCL2, IL-8, total bilirubin, and age as independent risk factors that constituted the immune-clinical prognostic model, which showed the strongest predictive value of 0.938 compared with those of the Chronic Liver Failure Consortium (CLIF-C) ACLF (0.785), Model for End-Stage Liver Disease (MELD) (0.669), and MELD-Na (0.723) scores (p < 0.05 for all).ConclusionThe serum cytokine/chemokine profiles correlated with the 90-day prognosis of patients with HBV-ACLF. The proposed composite immune-clinical prognostic model resulted in more accurate prognostic estimates than those of the CLIF-C ACLF, MELD, and MELD-Na scores.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1133656/fullprospective cohort studyLuminexprognostic modelCXCl2IL-8IL-6
spellingShingle Bingbing Zhu
Fangyuan Gao
Yuxin Li
Ke Shi
Yixin Hou
Jialiang Chen
Qun Zhang
Xianbo Wang
Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure
Frontiers in Immunology
prospective cohort study
Luminex
prognostic model
CXCl2
IL-8
IL-6
title Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure
title_full Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure
title_fullStr Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure
title_full_unstemmed Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure
title_short Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure
title_sort serum cytokine and chemokine profiles and disease prognosis in hepatitis b virus related acute on chronic liver failure
topic prospective cohort study
Luminex
prognostic model
CXCl2
IL-8
IL-6
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1133656/full
work_keys_str_mv AT bingbingzhu serumcytokineandchemokineprofilesanddiseaseprognosisinhepatitisbvirusrelatedacuteonchronicliverfailure
AT fangyuangao serumcytokineandchemokineprofilesanddiseaseprognosisinhepatitisbvirusrelatedacuteonchronicliverfailure
AT yuxinli serumcytokineandchemokineprofilesanddiseaseprognosisinhepatitisbvirusrelatedacuteonchronicliverfailure
AT keshi serumcytokineandchemokineprofilesanddiseaseprognosisinhepatitisbvirusrelatedacuteonchronicliverfailure
AT yixinhou serumcytokineandchemokineprofilesanddiseaseprognosisinhepatitisbvirusrelatedacuteonchronicliverfailure
AT jialiangchen serumcytokineandchemokineprofilesanddiseaseprognosisinhepatitisbvirusrelatedacuteonchronicliverfailure
AT qunzhang serumcytokineandchemokineprofilesanddiseaseprognosisinhepatitisbvirusrelatedacuteonchronicliverfailure
AT xianbowang serumcytokineandchemokineprofilesanddiseaseprognosisinhepatitisbvirusrelatedacuteonchronicliverfailure